Good morning, everyone.
We are continuing our study that resulted from a motion adopted by the committee on June 3, 2008. We're continuing our study of the decision of Atomic Energy of Canada Limited and the government to discontinue the MAPLE reactors project, together with the ramifications of this decision on the supply of isotopes.
We have with us today two witnesses: Michael Binder, president of the Canadian Nuclear Safety Commission; and Nigel Lockyer, director of TRIUMF. Welcome, gentlemen. Thank you both for being here today.
Mr. Binder, do you have a presentation to make?